IP Library Granted Patent US 8,343,078
Granted Patent B2
US 8,343,078 · App. 12/616,343 · Granted Jan 1, 2013

Methods for evaluating the integrity of a uterine cavity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,343,078
App. No.
12/616,343
Granted
Jan 1, 2013
Kind
B2
Abstract

Methods, systems and devices for evaluating the integrity of a uterine cavity. A method comprises introducing transcervically a probe into a patient's uterine cavity, providing a flow of a fluid (e.g., CO 2 ) through the probe into the uterine cavity and monitoring the rate of the flow to characterize the uterine cavity as perforated or non-perforated based on a change in the flow rate. If the flow rate drops to zero or close to zero, this indicates that the uterine cavity is intact and not perforated. If the flow rate does not drop to zero or close to zero, this indicates that a fluid flow is leaking through a perforation in the uterine cavity into the uterine cavity or escaping around an occlusion balloon that occludes the cervical canal.

Claims (26)

1. A method for detecting perforations in a patient's uterus, said method comprising:

transcervically introducing a probe into a uterine cavity of the patient;

expanding an expandable-collapsible frame to expand a fluid-tight wall on the probe in the uterine cavity;

introducing a flow of a fluid into the uterine cavity in a region between an external surface of the fluid-tight wall and an interior wall of the uterus, wherein the fluid comprises a gas; and

measuring a flow rate of the fluid as it is being introduced into the uterine cavity, wherein a measured flow rate which drops to a level below a predetermined threshold minimum level indicates that the uterus is not perforated.

2. The method of claim 1 , wherein the flow is introduced through the probe and the probe provides no outlet for flow from the uterine cavity.

3. The method of claim 1 , further comprising generating a signal, responsive to the flow rate, that characterizes the uterine cavity as at least one of perforated or non-perforated.

4. The method of claim 1 , further comprising generating a signal responsive to the flow rate not dropping below a predetermined level, that characterizes the uterine cavity as perforated.

5. The method of claim 4 , wherein the predetermined level is 0.05 slpm.

6. The method of claim 1 , further comprising generating a signal responsive to the flow rate dropping below a predetermined level, that characterizes the uterine cavity as non-perforated.

7. The method of claim 6 , wherein the predetermined level is 0.05 slpm.

8. The method of claim 1 , wherein measuring comprises measuring the flow rate over a predetermined first time interval after initiation of the flow.

9. The method of claim 8 , wherein the first time interval is at least 5 seconds.

10. The method of claim 8 , wherein the first time interval is in a range from 1 second to 60 seconds.

11. The method of claim 8 , wherein the first time interval is in a range from 10 seconds to 30 seconds.

12. The method of claim 8 , wherein measuring comprises measuring the flow rate over a second predetermined time interval after the first time interval.

13. The method of claim 12 wherein the second interval is at least 1 second.

14. The method of claim 12 wherein the second interval is at least 5 second.

15. The method of claim 12 wherein the second is at least 10 seconds.

16. The method of claim 1 , wherein measuring comprises providing a signal, responsive to the flow rate, that characterizes the uterine cavity as at least one of perforated or non-perforated, and wherein the signal is at least one of visual, aural and tactile.

17. The method of claim 1 further comprising, prior to introducing the flow, positioning a member within the cervical canal that prevents a flow of the fluid out of the uterine cavity.

18. The method of claim 17 , wherein the member is positioned about an exterior of the probe.

19. The method of claim 18 wherein the member is expanded in the cervical canal.

20. The method of claim 1 , wherein the probe has an energy-delivery surface on the fluid-tight wall for ablating uterine cavity tissue, and wherein the method further comprises disabling activation of the energy delivery surface responsive to the uterine cavity being characterized as perforated.

21. The method of claim 1 , wherein the probe has an energy-delivery surface on the fluid-tight wall for ablating uterine cavity tissue, and wherein the method further comprises enabling activation of the energy delivery surface responsive to the uterine cavity being characterized as non-perforated.

22. The method of claim 21 , further comprising, responsive to the uterine cavity being characterized as non-perforated, automatically activating the energy delivery surface.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: MINERVA SURGICAL, INC.
Reel/Frame 074721/0585 →
SECURITY INTEREST Recorded Jan 30, 2026
From: AXORA MEDICAL, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 074537/0617 →
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: MINERVA SURGICAL, INC.
Reel/Frame 057770/0451 →
SECURITY INTEREST Recorded Oct 8, 2021
From: MINERVA SURGICAL, INC.
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 057758/0137 →
SECURITY INTEREST Recorded Dec 31, 2019
From: MINERVA SURGICAL, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 051395/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2010
From: TOTH, AKOS
To: MINERVA SURGICAL, INC.
Reel/Frame 023904/0764 →